Supplementary Fig. S9 from Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy Article Swipe
Related Concepts
Blockade
Reprogramming
CTLA-4
Cancer research
Chemotherapy
Immune system
Tumor microenvironment
Medicine
Immunology
Chemistry
T cell
Internal medicine
Cell
Receptor
Biochemistry
Jiang Chen
,
Zohreh Amoozgar
,
Xin Liu
,
Shuichi Aoki
,
Zelong Liu
,
Sarah M. Shin
,
Aya Matsui
,
Alexei Hernandez
,
Zhangya Pu
,
Stefan Halvorsen
,
Pin‐Ji Lei
,
Meenal Datta
,
Lingling Zhu
,
Zhiping Ruan
,
Lei Shi
,
Daniel Staiculescu
,
Koetsu Inoue
,
Lance L. Munn
,
Dai Fukumura
,
Peigen Huang
,
Slim Sassi
,
Nabeel Bardeesy
,
Won Jin Ho
,
Rakesh K. Jain
,
Dan G. Duda
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.25523594.v1
· OA: W4393494874
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.25523594.v1
· OA: W4393494874
<p>Supplementary Fig. S9: Expression levels of Cxcr3 and its ligands are increased in ICC tissues after GC/dual ICB treatment in murine 425-ICC.</p>
Related Topics
Finding more related topics…